FINV Q4 2025 Earnings EPS Reported at 172 Stock Declines Amid Incomplete Disclosure Crescent Biopharma Inc CBIO Q1 2026 Earnings NarrowerThanExpected Loss Highlights Cost Discipline DOYU Q4 2025 Earnings Massive EPS Surprise as Company Returns to Profitability S Q1 2026 Earnings EPS Beats Estimates Stock Rises on BetterThanExpected Profitability ADCT Q1 2026 Earnings Narrowed Loss Beats Estimates Stock Surges Marker Therapeutics Q1 2026 Earnings Narrower Loss Beats Estimates as Biotech Advances Pipeline